Unbound MEDLINE

Urgency-free time interval as primary endpoint for evaluating the outcome of a randomized OAB treatment. International urogynecology journal and pelvic floor dysfunction [Int Urogynecol J Pelvic Floor Dysfunct] Journal article

 
TitleUrgency-free time interval as primary endpoint for evaluating the outcome of a randomized OAB treatment.
Author(s)Wang AC, Chen MC, Kuo WY, Lin YH, Wang YC, Lo TS 
InstitutionDivision of Female Pelvic Medicine and Reconstructive Surgery, Chang Gung Memorial Hospital, Linko, Taiwan. alexwang@cgmh.org.tw
SourceInt Urogynecol J Pelvic Floor Dysfunct 2009 Jul; 20(7):819-25.
AbstractINTRODUCTION AND
HYPOTHESIS: This study was conducted to determine whether urgency-free interval (UFI) was effective to evaluate the outcome of overactive bladder (OAB) and the correlation of changes between this parameter and urgency episodes.
METHODS: A randomized placebo-controlled trial was conducted involving 73 women with OAB. The interventions for a 12-week period included a vaginal electric stimulation and oxybutynin (2.5 mg) or placebo three times per day. Identical preintervention and postintervention assessments included the measurement of UFI and warning time (WT). The King's Health Questionnaire, Spearman's correlation coefficient (SCC), Kruskal-Wallis, Mann-Whitney U, and Wilcoxon-signed rank tests were used for analysis.
RESULTS: A positive and significant correlation between the improvements of WT and UFI was noted in the oxybutynin group (p = 0.009). In all groups, none of the SCC revealed significant correlation between the improvement of UFI and urgency episodes (all p >or= 0.145).
CONCLUSIONS: The efficacy of UFI in evaluating treatment outcome of OAB was comparable with that of WT in selected modality.
Languageeng
Pub Type(s)Journal Article
Research Support, Non-U.S. Gov't
PubMed ID19495544
  
Advertise on this site.